当前位置: 首页 > 期刊 > 《中国实用医药》 > 2011年第21期 > 正文
编号:12163281
冠心病合并糖尿病患者胰岛素抵抗及其抵抗素相关性分析(3)
http://www.100md.com 2011年7月25日 张晓丹 张月兰 赵红丽
第1页

    参见附件(2999KB,3页)。

     [8] Frankel DS, Vasan RS, D'Agostino RB Sr, et al. Resistin,adiponectin, and risk of heart failure the framingham offspring study. Am Coll Cardiol, 2009, 53(9): 754-762.

    [9] Piestrzeniewicz K, Uczak K, Komorowski J, et al. Resistin increases with obesity and atherosclerotic risk factors in patients with myocardial infarction. Metabolism, 2008,57(4): 488-493.

    [10] Gao J, Chang Chua C, Chen Z, et al. Resistin, an adipocytokine, offers protection against acute myocardial infarction.Mol Cell Cardiol, 2007, 43(5): 601-609.

    [11] Wai. I, Ace TM, Matthews D R. The assessment of insulin resistance in man. Diabet Med, 2002, 19:527-534.

    [12] On YK, Park HK, H yonMS, et al.Serum resistin as a biological marker for coronary artery disease and restenos is in type 2 diabetic patients. Circ J, 2007, 71(6): 868-873.

    [13] Wang H, Chen DY, Cao J, et al. High serum resistin level may be an indicator of the severity of coronary disease in acute coronary syndrome. Chin Med Sci J, 2009, 24(3): 161-166.

    [14] de Luis DA, Sagrado MG, Conde R, et al. Relation of resistin levels with cardiovascular risk factors,insulin resistance and inflammation in nave diabetes obese patients ......

您现在查看是摘要介绍页,详见PDF附件(2999KB,3页)